Fingerprint
Dive into the research topics of 'A phase III trial of pemetrexed plus gemcitabine versus gemcitabine in patients with unresectable or metastatic pancreatic cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Helmut Oettle, D. Richards, R. K. Ramanathan, J. L. van Laethem, M. Peeters, M. Fuchs, A. Zimmermann, W. John, D. Von Hoff, M. Arning, H. L. Kindler
Research output: Contribution to journal › Article › peer-review